|
||||||||||||||||
|
||||||||||||||||
| HUM-MOLGEN -> mail archive | Search | register for news alert (free) | |||||||||||||||
| Martin Kennedy: BIOT: Non-isotopic sequencing, patient requests... | ||||||||||||||||
|
[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index] |
||||||||||||||||
|
To: Multiple recipients of list HUM-MOLGEN <HUM-MOLGEN@NIC.SURFNET.NL> Subject: BIOT: Non-isotopic sequencing, patient requests... From: Martin Kennedy <MKENNEDY@chmeds.ac.nz> Date: Mon, 26 Jun 1995 11:16:09 +1200
Date sent: 26-JUN-1995 11:14:19
BIOT SUMMARY:
Three messages:
(1) Non isotopic sequencing request
(2) Comment regarding patient request for help on
(3) Editors comment on the preceding message..
Arthur Bergen (on leave)
Martin Kennedy
BIOT section editros
8< ======================= cut here ======================= >8
(1) Non isotopic sequencing:
Hi, I am interested in non-isotopic sequencing (prob. usb/dix products).
Anyone can share their experiences with me.
Thanks.
ZAM
zam@kb.usm.my
8< ======================= cut here ======================= >8
(2) Comment regarding patient request...
From: "Stephen Karp (AJHG)" <karp@MEDCOR.MCGILL.CA>
Subject: Re: BIOT: 3 messages...
I would like to state that the 2nd of these messages is not appropriate for
this list. There are many other places on the net where patients ask such
questions. I feel sorry for this gentleman, but if such patient requests
invade this list then they will overwhelm what is a useful and interesting
about this list. I suggest that such patient questions should be rejected from
this list.
8< ======================= cut here ======================= >8
(3) Editors comment on the preceding message...
I forwarded the original message for help on neurofibrosarcoma/p53
and RAS to HUM-MOLGEN because I thought it at least partially appropriate
for the BIOT section; it seemed to be a rational request for information
on clinical trials for the disease, as well as for information about p53
and RAS.
I agree with Stephen Karp's sentiment, but at present I (and
other HUM-MOLGEN editors I have consulted) feel each message needs
to be assessed individually for relevance to HUM-MOLGEN, and
posted or returned to the sender accordingly.
Sincerely,
Martin Kennedy
NNNN NN Martin A Kennedy (E-mail = mkennedy@chmeds.ac.nz) ZZZZZZZ
NN NN NN Cytogenetic and Molecular Oncology Unit ZZZ
NN NN NN Christchurch School of Medicine ZZZ
NN NNNN Christchurch, New Zealand ZZZZZZZ
Phone (64-3)364-0880 Fax (64-3)364-0750
|
||||||||||||||||
|
||||||||||||||||
|
Mail converted by |
||||||||||||||||